Table 3.

Cytokine and other indicators 24, 48, 72 hours after ECMO.

		XBJ group	Control group	p
		N = 21	N = 20
24 hours after ECMO
	Interleukin-6 (pg/mL)	171.43 $\pm$ 26.68	213.20 $\pm$ 41.28	0.001
	Tumor necrosis factor $\alpha$ (pg/mL)	1.81 $\pm$ 0.43	2.20 $\pm$ 0.53	0.014
	Interleukin-8 (pg/mL)	4.78 $\pm$ 1.30	5.55 $\pm$ 1.33	0.071
	Interleukin-10 (pg/mL)	2.03 $\pm$ 0.32	2.06 $\pm$ 0.38	0.735
	Hemoglobin (g/L)	125.43 $\pm$ 12.46	113.25 $\pm$ 11.30	0.002
	Platelet ($\times$109/L)	174.10 $\pm$ 31.76	152.15 $\pm$ 35.41	0.043
	D-Dimer (ng/mL)	1055.95 $\pm$ 221.73	1348.95 $\pm$ 230.57	0.000
	C reactive protein (mg/L)	78.90 $\pm$ 22.05	89.15 $\pm$ 18.09	0.113
48 hours after ECMO
	Interleukin-6 (pg/mL)	75.19 $\pm$ 20.63	130.10 $\pm$ 27.82	0.000
	Tumor necrosis factor $\alpha$ (pg/mL)	1.13 $\pm$ 0.19	1.64 $\pm$ 0.49	0.000
	Interleukin-8 (pg/mL)	2.52 $\pm$ 1.42	3.11 $\pm$ 0.69	0.105
	Interleukin-10 (pg/mL)	1.01 $\pm$ 0.20	1.07 $\pm$ 0.24	0.343
	Hemoglobin (g/L)	113.90 $\pm$ 13.10	100.00 $\pm$ 6.94	0.000
	Platelet ($\times$109/L)	135.19 $\pm$ 19.91	118.10 $\pm$ 18.95	0.008
	D-Dimer (ng/mL)	1388.10 $\pm$ 343.66	1968.0 $\pm$ 405.28	0.000
	C reactive protein (mg/L)	94.71 $\pm$ 12.29	107.70 $\pm$ 17.21	0.008
72 hours after ECMO
	Interleukin-6 (pg/mL)	57.47 $\pm$ 11.02	103.70 $\pm$ 22.63	0.000
	Tumor necrosis factor $\alpha$ (pg/mL)	1.20 $\pm$ 0.20	1.73 $\pm$ 0.39	0.000
	Interleukin-8 (pg/mL)	2.46 $\pm$ 0.56	3.38 $\pm$ 0.70	0.000
	Interleukin-10 (pg/mL)	1.31 $\pm$ 0.20	1.27 $\pm$ 0.24	0.518
	Hemoglobin (g/L)	98.95 $\pm$ 15.49	84.75 $\pm$ 6.88	0.001
	Platelet ($\times$109/L)	120.00 $\pm$ 22.22	95.80 $\pm$ 13.54	0.000
	D-Dimer (ng/mL)	1547.62 $\pm$ 426.19	2349.35 $\pm$ 528.94	0.000
	C reactive protein (mg/L)	114.19 $\pm$ 17.61	131.45 $\pm$ 26.03	0.019
Average ECMO flow on day 1 (L/min)		2.85 $\pm$ 0.31	2.88 $\pm$ 0.39	0.768
Average ECMO flow on day 2 (L/min)		2.88 $\pm$ 0.32	2.80 $\pm$ 0.24	0.362
Average ECMO flow on day 3 (L/min)		2.14 $\pm$ 0.40	2.38 $\pm$ 0.33	0.044

ECMO, extracorporeal membrane oxygenation; XBJ, Xuebijing.